Logo image of CMED.CA

Cannimed Therapeutics Inc (CMED.CA) Stock Price, Quote, News and Overview

TSX:CMED - Toronto Stock Exchange -

27  -1.5 (-5.26%)

CMED.CA Quote, Performance and Key Statistics

Cannimed Therapeutics Inc

TSX:CMED (5/1/2018, 4:30:00 PM)

27

-1.5 (-5.26%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High46
52 Week Low7.32
Market Cap668.44M
Shares24.76M
FloatN/A
Yearly DividendN/A
Dividend YieldN/A
PE245.45
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


CMED.CA short term performance overview.The bars show the price performance of CMED.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80 100

CMED.CA long term performance overview.The bars show the price performance of CMED.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of CMED.CA is 27 null. In the past month the price decreased by -17.13%. In the past year, price increased by 138.94%.

Cannimed Therapeutics Inc / CMED Daily stock chart

About CMED.CA

Company Profile

CanniMed Therapeutics Inc is a biopharmaceutical company. The principal business activities of CanniMed along with its subsidiaries is plant biotechnology research, product development and the production of plant based materials.

Company Info

Cannimed Therapeutics Inc

1 Plant Technology Road

Saskatoon SK S7K 3J8

CEO: Brent Zettl

Phone: +1 855 787-1577

Cannimed Therapeutics Inc / CMED.CA FAQ

What is the stock price of Cannimed Therapeutics Inc today?

The current stock price of CMED.CA is 27 null. The price decreased by -5.26% in the last trading session.


What is the ticker symbol for Cannimed Therapeutics Inc stock?

The exchange symbol of Cannimed Therapeutics Inc is CMED and it is listed on the Toronto Stock Exchange exchange.


On which exchange is CMED.CA stock listed?

CMED.CA stock is listed on the Toronto Stock Exchange exchange.


What is Cannimed Therapeutics Inc worth?

Cannimed Therapeutics Inc (CMED.CA) has a market capitalization of 668.44M null. This makes CMED.CA a Small Cap stock.


What are the support and resistance levels for Cannimed Therapeutics Inc (CMED.CA) stock?

Cannimed Therapeutics Inc (CMED.CA) has a support level at 13.91 and a resistance level at 27.01. Check the full technical report for a detailed analysis of CMED.CA support and resistance levels.


Should I buy Cannimed Therapeutics Inc (CMED.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Cannimed Therapeutics Inc (CMED.CA) stock pay dividends?

CMED.CA does not pay a dividend.


What is the Price/Earnings (PE) ratio of Cannimed Therapeutics Inc (CMED.CA)?

The PE ratio for Cannimed Therapeutics Inc (CMED.CA) is 245.45. This is based on the reported non-GAAP earnings per share of 0.11 and the current share price of 27 null. Check the full fundamental report for a full analysis of the valuation metrics for CMED.CA.


CMED.CA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to CMED.CA. When comparing the yearly performance of all stocks, CMED.CA is one of the better performing stocks in the market, outperforming 91.46% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CMED.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CMED.CA. CMED.CA has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CMED.CA Financial Highlights

Over the last trailing twelve months CMED.CA reported a non-GAAP Earnings per Share(EPS) of 0.11. The EPS increased by 103.82% compared to the year before.


Industry RankSector Rank
PM (TTM) 15%
ROA 2.18%
ROE 2.76%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%215.79%
Sales Q2Q%41.25%
EPS 1Y (TTM)103.82%
Revenue 1Y (TTM)146.58%

CMED.CA Ownership and Analysts


Ownership
Inst Owners16.45%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A